Ignite Creation Date:
2024-05-05 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00157612
Status:
COMPLETED
Last Update Posted:
2018-10-29
First Post:
2005-09-07
Brief Title:
A Clinical Pathway for Nursing Home Acquired Pneumonia
Sponsor:
McMaster University
Organization:
McMaster University
Study Overview
Official Title:
A Randomized Control Trial of a Clinical Pathway for Nursing Home Pneumonia
Status:
COMPLETED
Status Verified Date:
2018-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Nursing home residents are frequently transferred to hospital for management of pneumonia This often leads to hospital related complications and is a burden on the acute care health system The purpose of this study is to assess whether managing residents with pneumonia and lower respiratory tract infection on site in the nursing home can reduce hospital admissions and can reduce complications and improve quality of life for residents We have randomized residents with nursing home acquired pneumonia to on-site management using a clinical pathway versus usual care
Detailed Description:
We conducted a cluster-randomized controlled trial where nursing homes were randomized to either use of a clinical pathway or usual care for management of nursing home acquired pneumonia The clinical pathway included chest radiographs performed on-site in the nursing home by a mobile x-ray unit use of hypodermocylysis subcutaneous infusion for re-hydration administration of an oral antimicrobials and use of pulse oximetry to assess oxygenation The main outcomes were hospital admission rate and length of stay Secondary outcomes included health related quality of life rates of both infectious and non-infectious complications within four weeks of onset of symptoms mortality rate of residents with pneumonia death from all causes within 30 days of onset of symptoms Time to stabilization of vital signs as well as functional status at four weeks were assessed
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| long term care | OTHER | McMaster University | None |